PL405077A1 - Zastosowanie alpha-cyklodrkstryny do wytwarzania leku do zmniejszania biegunki - Google Patents

Zastosowanie alpha-cyklodrkstryny do wytwarzania leku do zmniejszania biegunki

Info

Publication number
PL405077A1
PL405077A1 PL405077A PL40507703A PL405077A1 PL 405077 A1 PL405077 A1 PL 405077A1 PL 405077 A PL405077 A PL 405077A PL 40507703 A PL40507703 A PL 40507703A PL 405077 A1 PL405077 A1 PL 405077A1
Authority
PL
Poland
Prior art keywords
cyclodextrin
medicament
manufacture
alpha
reducing diarrhea
Prior art date
Application number
PL405077A
Other languages
English (en)
Other versions
PL220776B1 (pl
Inventor
Catherine Jen
Joseph D. Artiss
Original Assignee
Soho Flordis International Pty Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soho Flordis International Pty Ltd. filed Critical Soho Flordis International Pty Ltd.
Publication of PL405077A1 publication Critical patent/PL405077A1/pl
Publication of PL220776B1 publication Critical patent/PL220776B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/80—Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14—Organic oxygen compounds
    • A21D2/18—Carbohydrates
    • A21D2/181—Sugars or sugar alcohols
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14—Organic oxygen compounds
    • A21D2/18—Carbohydrates
    • A21D2/186—Starches; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L15/00—Egg products; Preparation or treatment thereof
    • A23L15/30—Addition of substances other than those covered by A23L15/20 – A23L15/25
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
    • A23L25/10—Peanut butter
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/88—Taste or flavour enhancing agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
    • A23L5/27—Removal of unwanted matter, e.g. deodorisation or detoxification by chemical treatment, by adsorption or by absorption
    • A23L5/273—Removal of unwanted matter, e.g. deodorisation or detoxification by chemical treatment, by adsorption or by absorption using adsorption or absorption agents, resins, synthetic polymers, or ion exchangers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/109—Types of pasta, e.g. macaroni or noodles
    • A23L7/111—Semi-moist pasta, i.e. containing about 20% of moist; Moist packaged or frozen pasta; Pasta fried or pre-fried in a non-aqueous frying medium, e.g. oil; Packaged pasta to be cooked directly in the package
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/117—Flakes or other shapes of ready-to-eat type; Semi-finished or partly-finished products therefor
    • A23L7/126—Snacks or the like obtained by binding, shaping or compacting together cereal grains or cereal pieces, e.g. cereal bars
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L9/00—Puddings; Cream substitutes; Preparation or treatment thereof
    • A23L9/10—Puddings; Dry powder puddings
    • A23L9/12—Ready-to-eat liquid or semi-liquid desserts, e.g. puddings, not to be mixed with liquids, e.g. water, milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P30/00—Shaping or working of foodstuffs characterised by the process or apparatus
    • A23P30/40—Foaming or whipping
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Edible Oils And Fats (AREA)
  • Fodder In General (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Wynalazek dotyczy zastosowania ?-cyklodekstryny do wytwarzania leku do zmniejszania biegunki, w którym wymagajacemu tego podmiotowi podaje sie wystarczajaca ilosc leku do zmniejszenia biegunki, przy czym stosunek ilosci podawanej ?-cyklodekstryny i ilosci tluszczu spozywanego dziennie przez wymieniony podmiot wynosi od 1:20 do 1:3 wagowo.
PL405077A 2002-08-19 2003-07-29 Zastosowanie α-cyklodekstryny do wytwarzania leku do zmniejszania biegunki PL220776B1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40436602P 2002-08-19 2002-08-19
US46184703P 2003-04-11 2003-04-11
US48644003P 2003-07-14 2003-07-14

Publications (2)

Publication Number Publication Date
PL405077A1 true PL405077A1 (pl) 2013-12-09
PL220776B1 PL220776B1 (pl) 2016-01-29

Family

ID=31892100

Family Applications (6)

Application Number Title Priority Date Filing Date
PL396944A PL220645B1 (pl) 2002-08-19 2003-07-29 Zastosowanie α-cyklodekstryny do wytwarzania leku do ułatwiania utraty masy ciała
PL405074A PL220643B1 (pl) 2002-08-19 2003-07-29 Zastosowanie α-cyklodekstryny do wytwarzania leku do obniżania poziomów trójglicerydów
PL405076A PL220779B1 (pl) 2002-08-19 2003-07-29 Zastosowanie α-cyklodekstryny do wytwarzania leku do obniżania poziomów leptyny, poziomów insuliny lub oporności na insulinę
PL375374A PL213863B1 (pl) 2002-08-19 2003-07-29 Konsumpcyjny maczny produkt zywnosciowy, konsumpcyjny niemaczny produkt zywnosciowy, sposób polepszania organoleptycznych wlasciwosci zawierajacego tluszcz konsumpcyjnego produktu zywnosciowego i sposób zmniejszania dostepnosci biologicznej tluszczu w konsumpcyjnym zawierajacym tluszcz produkcie zywnosciowym
PL405077A PL220776B1 (pl) 2002-08-19 2003-07-29 Zastosowanie α-cyklodekstryny do wytwarzania leku do zmniejszania biegunki
PL405075A PL220780B1 (pl) 2002-08-19 2003-07-29 Zastosowanie α-cyklodekstryny do wytwarzania leku do podwyższania poziomu cholesterolu lipoproteinowego o wysokiej gęstości (HDL) oraz do zmniejszania stosunku cholesterol/HDL

Family Applications Before (4)

Application Number Title Priority Date Filing Date
PL396944A PL220645B1 (pl) 2002-08-19 2003-07-29 Zastosowanie α-cyklodekstryny do wytwarzania leku do ułatwiania utraty masy ciała
PL405074A PL220643B1 (pl) 2002-08-19 2003-07-29 Zastosowanie α-cyklodekstryny do wytwarzania leku do obniżania poziomów trójglicerydów
PL405076A PL220779B1 (pl) 2002-08-19 2003-07-29 Zastosowanie α-cyklodekstryny do wytwarzania leku do obniżania poziomów leptyny, poziomów insuliny lub oporności na insulinę
PL375374A PL213863B1 (pl) 2002-08-19 2003-07-29 Konsumpcyjny maczny produkt zywnosciowy, konsumpcyjny niemaczny produkt zywnosciowy, sposób polepszania organoleptycznych wlasciwosci zawierajacego tluszcz konsumpcyjnego produktu zywnosciowego i sposób zmniejszania dostepnosci biologicznej tluszczu w konsumpcyjnym zawierajacym tluszcz produkcie zywnosciowym

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL405075A PL220780B1 (pl) 2002-08-19 2003-07-29 Zastosowanie α-cyklodekstryny do wytwarzania leku do podwyższania poziomu cholesterolu lipoproteinowego o wysokiej gęstości (HDL) oraz do zmniejszania stosunku cholesterol/HDL

Country Status (23)

Country Link
US (4) US6890549B2 (pl)
EP (4) EP2138190B1 (pl)
JP (3) JP4418751B2 (pl)
CN (1) CN100542609C (pl)
AT (1) ATE442165T1 (pl)
AU (1) AU2003259235B2 (pl)
BR (1) BRPI0309572B1 (pl)
CA (2) CA2480668C (pl)
CY (1) CY1115026T1 (pl)
DE (1) DE60329168D1 (pl)
DK (2) DK2138190T3 (pl)
ES (1) ES2457017T3 (pl)
HK (2) HK1072184A1 (pl)
IL (2) IL164332A0 (pl)
MA (1) MA27959A1 (pl)
MX (1) MXPA04012880A (pl)
NO (2) NO334081B1 (pl)
NZ (1) NZ535665A (pl)
PL (6) PL220645B1 (pl)
PT (1) PT2138190E (pl)
SI (1) SI2138190T1 (pl)
WO (1) WO2004016101A2 (pl)
ZA (1) ZA200407806B (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE442165T1 (de) * 2002-08-19 2009-09-15 Art Jen Complexus Inc Zusammensetzungen mit einem nahrungsfett- komplexbildner und anwendungsverfahren
US20040116382A1 (en) * 2002-12-13 2004-06-17 Plank David W. Food products containing cyclodextrins having beneficial hypocholesterolemic effects and method of making and communicating the benefit of such products
EP1447013A1 (en) * 2003-02-14 2004-08-18 Wacker-Chemie GmbH Method for reducing the glycemic index of food
US20040180125A1 (en) * 2003-03-11 2004-09-16 Plank David W. Cyclodextrin-containing compositions and methods
US7335386B2 (en) 2003-07-30 2008-02-26 Gerneral Mills, Inc. Method for preventing acrylamide formation in food products and food intermediates
US7105195B2 (en) * 2003-07-25 2006-09-12 General Mills, Inc. Reduced trans fat product
CA2547934C (en) 2004-02-19 2013-05-21 Abbott Laboratories Methods of using gamma cyclodextrin to control blood glucose and insulin secretion
US7780873B2 (en) * 2004-02-23 2010-08-24 Texas A&M University System Bioactive complexes compositions and methods of use thereof
WO2006002273A1 (en) * 2004-06-22 2006-01-05 General Mills, Inc. Viscous fat compositions having low amounts of trans-fat, methods and products
US20070003681A1 (en) * 2005-06-30 2007-01-04 Kraft Foods Holdings, Inc. Stable aerated food products containing oil and cyclodextrin
WO2007073543A2 (en) * 2005-12-22 2007-06-28 General Mills, Inc. Method of preferentially reducing absorption of saturated fat and compositions
US8137729B2 (en) * 2005-12-22 2012-03-20 General Mills, Inc. Method of making complexed fat compositions
JP2008031055A (ja) * 2006-06-29 2008-02-14 Shunkosha:Kk 酢酸を含有してなる摂取用組成物
US20090023682A1 (en) * 2007-07-19 2009-01-22 Joseph Artiss Composition Comprising Dietary Fat Complexer and Methods of Using Same
US20100112122A1 (en) * 2008-04-30 2010-05-06 Yun-Jeong Hong Method of preferentially reducing absorbability of saturated fatty acids
MX2010012442A (es) 2008-05-13 2011-10-11 Astrazeneca Ab Sal de fumarato de 4-(3-cloro-2-fluoroanilino)-7-metoxi-6-{[1-(n-m etilcarbamoilmetil) piperidin-4-il]oxi}quinazolina.
WO2011114239A2 (en) * 2010-03-13 2011-09-22 Eastpond Laboratories Limited Fat-binding compositions
PL2568827T3 (pl) * 2010-05-14 2018-10-31 Omega Pharma Innovation & Development Nv Kompozycja do redukowania wchłaniania tłuszczu przyjmowanego z pokarmem
CA2852904C (en) 2010-10-19 2019-01-08 University Of Miami Assays, methods and kits for predicting renal disease and personalized treatment strategies
WO2012090018A1 (en) 2010-12-31 2012-07-05 Eastpond Laboratories Limited Cellular hydration compositions containing cyclodextrins
US20120171184A1 (en) 2010-12-31 2012-07-05 Lajos Szente Cellular hydration compositions
MX371073B (es) 2012-04-13 2020-01-15 L&F Res Llc Método para utilizar ciclodextrina.
US9636048B2 (en) 2013-03-14 2017-05-02 Group Mee Llc Specialized sensors and techniques for monitoring personal activity
JP6735964B2 (ja) * 2016-04-28 2020-08-05 株式会社ハートテック 血糖値上昇抑制の加工食品
KR20200107927A (ko) 2017-09-28 2020-09-16 아스데라 엘엘씨 인지질 조절장애를 수반하는 질환 및 장애에서의 시클로덱스트린의 용도
JP7120068B2 (ja) * 2018-02-28 2022-08-17 トヨタ紡織株式会社 動物の育成方法及び育成装置
US11660283B2 (en) 2018-12-19 2023-05-30 Joyn Botanicals Ltd. Cannabinoid-containing composition
CA3174816A1 (en) 2020-04-06 2021-10-14 Lajos Szente Compositions for promoting cellular hydration
CN115104733A (zh) * 2021-03-18 2022-09-27 南京壹盛康品生物科技有限公司 α-环糊精在制备降脂食品、保健品及药物中的应用
CN115067393B (zh) * 2022-05-31 2024-04-12 古茗科技集团有限公司 打发辅助剂、其的制备方法、应用及奶盖打发方法

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5210448A (en) 1975-07-15 1977-01-26 Teijin Ltd Method of producing processed oil and fat food
JPS6049752A (ja) 1983-08-29 1985-03-19 Sanyuu Shoji Kk 栄養食品組成物
JPS6094912A (ja) 1983-10-28 1985-05-28 Masashige Suzuki 体内中性脂肪低減剤
JPS60149752A (ja) 1984-01-11 1985-08-07 Furukawa Electric Co Ltd:The 高力アルミニウム合金導体の製造方法
JPS60219720A (ja) 1984-04-16 1985-11-02 株式会社村田製作所 電気二重層コンデンサとその製造方法
JPS6211072A (ja) * 1985-07-08 1987-01-20 Kokusai:Kk 痩身用食品
FR2601959B1 (fr) 1986-07-24 1988-12-02 Monserbio Gie Procede d'elimination du cholesterol contenu dans une matiere grasse d'origine animale et matiere grasse appauvrie en cholesterol obtenue
US5232725A (en) 1989-03-14 1993-08-03 S.A.N. Corman Process for reducing the content of cholesterol and of free fatty acids in an animal fat
JPH0722483B2 (ja) 1989-03-31 1995-03-15 鐘淵化学工業株式会社 ケーキ用水中油型油脂組成物及びそれを利用したケーキ類の製造法
US5264241A (en) 1989-06-29 1993-11-23 Roquette Freres Process for manufacturing dairy products with a reduced sterol content
US5264226A (en) 1989-07-12 1993-11-23 Roquette Freres Process for preparing dairy products with a low content of sterols, particularly of cholesterol
JPH07115934B2 (ja) 1989-10-12 1995-12-13 日本特殊陶業株式会社 β―サイアロン焼結体
US5198250A (en) * 1990-07-16 1993-03-30 Lipotech Partners Limited Partnership Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using
IT1243192B (it) 1990-08-09 1994-05-24 Staroil Ltd Complessi di acidi grassi polinsaturi a lunga catena e di loro derivati, con ciclodestrine
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
JPH04237477A (ja) * 1991-01-22 1992-08-25 Ezaki Glico Co Ltd メレンゲの製造法
JPH04333575A (ja) 1991-01-29 1992-11-20 Nippon Parkerizing Co Ltd チタン含有金属材料上に複合被覆膜層を形成する方法
JP2646160B2 (ja) 1991-03-08 1997-08-25 美穂 田中 愛玩鳥類用飼料とその製造法
EP0602149A1 (en) * 1991-09-06 1994-06-22 Commonwealth Scientific And Industrial Research Organisation Composition and method for reducing cholesterol concentration
JPH05113603A (ja) 1991-10-23 1993-05-07 Tohoku Ricoh Co Ltd オーバーヘツドプロジエクタ装置
US5254541A (en) * 1991-11-15 1993-10-19 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indole/cyclodextrin complex
JP2559311B2 (ja) 1991-12-12 1996-12-04 本田技研工業株式会社 多連スロットルボディの燃料配管構造
US5215922A (en) * 1992-02-05 1993-06-01 The Board Of Governors Of Wayne State University Method and compositions for the determination of serum calcium using aersenazo III
JPH05298849A (ja) 1992-04-16 1993-11-12 Sony Corp 浮上型磁気ヘッド装置
JPH05298850A (ja) 1992-04-22 1993-11-12 Hitachi Ltd 磁気記録装置およびそのスライダ
JPH07102113B2 (ja) 1992-11-18 1995-11-08 日成興産株式会社 痩身用食品
JPH0813257B2 (ja) * 1992-11-25 1996-02-14 日成興産株式会社 痩身用食品
JP3230884B2 (ja) * 1993-03-18 2001-11-19 日清製油株式会社 冷凍解凍耐性のあるクリーム状組成物及びその製造方法
JP2605208B2 (ja) 1993-04-15 1997-04-30 逸郎 松島 痩身用食品
JP2510943B2 (ja) 1993-06-07 1996-06-26 株式会社ドクターマインツ 痩身用食品
DE4331565A1 (de) * 1993-09-16 1995-03-23 Consortium Elektrochem Ind Verfahren zur Reduktion des Gehalts an Triglyceriden im Eigelb und in eigelbhaltigen Produkten
JPH07115934A (ja) 1993-10-22 1995-05-09 Hairu:Kk 痩身用食品
JPH07115935A (ja) 1993-10-22 1995-05-09 Hairu:Kk 痩身用食品
US5894029A (en) 1994-03-21 1999-04-13 Purebred Pet Products, Inc. Method of making pet snack food
JPH09501186A (ja) * 1994-11-12 1997-02-04 株式会社エルジ化学 コレステリルエステル運搬蛋白質阻害ペプチドおよびこれを含む動脈硬化症のための予防および治療剤
AU691409B2 (en) 1995-02-22 1998-05-14 Cerestar Usa, Inc. Process for reducing sterols and free fatty acids from animal fat
JP3375780B2 (ja) 1995-03-29 2003-02-10 三井化学株式会社 重包装袋用ポリエチレン樹脂組成物およびその組成物からなる重包装袋用ポリエチレン樹脂フィルム
US5738898A (en) 1995-03-31 1998-04-14 Board Of Trustees Operating Michigan State University Process for reducing sterols in eggs
US5560950A (en) 1995-05-31 1996-10-01 Campbell Soup Company Free fatty acid removal from used frying fat
US5532009A (en) 1995-06-07 1996-07-02 The Procter & Gamble Company Fat substitutes containing water soluble beta-carotene
JP2934658B2 (ja) 1995-12-25 1999-08-16 美穂 田中 クロレラエキス粉末の製造法
IL117773A (en) 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
US5965449A (en) * 1996-07-03 1999-10-12 Forbes Medi-Tech, Inc. Method of assessing risk for cardiovascular disease and other disorders and phytosterol-based compositions useful in preventing and treating cardiovascular disease and other disorders
JP2000116337A (ja) 1998-10-09 2000-04-25 Nippon Shokuhin Kako Co Ltd ペットフード
US6129945A (en) 1998-12-10 2000-10-10 Michael E. George Methods to reduce free fatty acids and cholesterol in anhydrous animal fat
JP2002306119A (ja) * 2001-04-17 2002-10-22 Toyo Olive Co Ltd 健康維持機能に優れたオリーブマヨネーズの製造法
US20030190402A1 (en) 2002-04-04 2003-10-09 Mcbride Christine Reduced fat foodstuff with improved flavor
US20030232068A1 (en) * 2002-06-14 2003-12-18 Lewandowski Daniel J. Food product having increased bile acid binding capacity
ATE442165T1 (de) * 2002-08-19 2009-09-15 Art Jen Complexus Inc Zusammensetzungen mit einem nahrungsfett- komplexbildner und anwendungsverfahren
US20040116382A1 (en) * 2002-12-13 2004-06-17 Plank David W. Food products containing cyclodextrins having beneficial hypocholesterolemic effects and method of making and communicating the benefit of such products

Also Published As

Publication number Publication date
IL164332A0 (en) 2005-12-18
EP2138190A3 (en) 2010-05-12
NO334081B1 (no) 2013-12-09
EP2138190A2 (en) 2009-12-30
EP2641615A2 (en) 2013-09-25
US9326539B2 (en) 2016-05-03
JP2013177448A (ja) 2013-09-09
JP5865296B2 (ja) 2016-02-17
PL396944A1 (pl) 2012-03-26
NO20130555L (no) 2004-11-24
EP2641615A3 (en) 2014-01-08
EP1478401A4 (en) 2007-10-24
EP1478401A2 (en) 2004-11-24
CA2480668A1 (en) 2004-02-26
PL405074A1 (pl) 2013-12-09
AU2003259235A1 (en) 2004-03-03
US8586076B2 (en) 2013-11-19
US6890549B2 (en) 2005-05-10
PL405075A1 (pl) 2013-12-09
US20120309712A1 (en) 2012-12-06
EP1478401B1 (en) 2009-09-09
PL375374A1 (pl) 2005-11-28
JP2009298820A (ja) 2009-12-24
CA2480668C (en) 2009-11-24
US20140107067A1 (en) 2014-04-17
PL405076A1 (pl) 2013-12-09
US8101201B2 (en) 2012-01-24
CA2677430A1 (en) 2004-02-26
DK2138190T3 (da) 2014-05-12
AU2003259235B2 (en) 2007-08-23
BRPI0309572B1 (pt) 2017-02-21
CN1662258A (zh) 2005-08-31
US20050019375A1 (en) 2005-01-27
JP2005536205A (ja) 2005-12-02
EP2623120B1 (en) 2020-04-01
EP2623120A3 (en) 2013-11-13
NO20044516L (no) 2004-11-24
CY1115026T1 (el) 2016-12-14
PL220776B1 (pl) 2016-01-29
NO339166B1 (no) 2016-11-14
BR0309572A (pt) 2005-02-09
HK1072184A1 (en) 2005-08-19
JP4418751B2 (ja) 2010-02-24
EP2138190B1 (en) 2014-02-12
DE60329168D1 (de) 2009-10-22
US20040120984A1 (en) 2004-06-24
JP5448683B2 (ja) 2014-03-19
PL220643B1 (pl) 2015-11-30
DK1478401T3 (da) 2010-01-18
CN100542609C (zh) 2009-09-23
IL164332A (en) 2010-11-30
SI2138190T1 (sl) 2014-05-30
EP2623120A2 (en) 2013-08-07
ATE442165T1 (de) 2009-09-15
PL220780B1 (pl) 2016-01-29
WO2004016101A3 (en) 2004-04-29
NZ535665A (en) 2008-03-28
MXPA04012880A (es) 2005-07-05
HK1140407A1 (en) 2010-10-15
WO2004016101A2 (en) 2004-02-26
PL220779B1 (pl) 2016-01-29
ES2457017T3 (es) 2014-04-24
PT2138190E (pt) 2014-04-14
CA2677430C (en) 2014-02-18
PL213863B1 (pl) 2013-05-31
MA27959A1 (fr) 2006-07-03
ZA200407806B (en) 2005-12-28
PL220645B1 (pl) 2015-11-30

Similar Documents

Publication Publication Date Title
PL405077A1 (pl) Zastosowanie alpha-cyklodrkstryny do wytwarzania leku do zmniejszania biegunki
NL300889I2 (nl) Trifluridine in combinatie met tipiracilhydrochloride
CR10838A (es) Derivados de 2,3-dihidroimidazol [1,2-c] quinazolina sustituidos, de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
AU2804400A (en) Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
ATE378058T1 (de) Cannabis extrakten pharmazeutische zusammensetzung
NO20044699L (no) Vaginalpleiesammensetning
BR0015188A (pt) Composições farmacêuticas
MY140010A (en) Purine compounds and use thereof as cannabinoid receptor ligands
BG106451A (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
MXPA05009194A (es) Estuche generador de espuma que contiene un despachador generador de espuma y una composicion de alta viscosidad.
IL157208A0 (en) 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
EP1541151A4 (en) TREATMENT AGAINST GLAUCOMA BASED ON RHO KINASE INHIBITORS AND PROSTAGLANDINS
TW200607799A (en) Therapeutic compounds: pyridine as scaffold
NO20040096L (no) Taxol-forbedringsforbindelser
GEP20135912B (en) 1-benzyl-3- hydroxymethylindazole derivatives and use thereat treatment of diseases based on mcp-1, cx3cr1 and p40 expression
NO20052490D0 (no) Dagsdoseringsenheter for melatonin.
TW200633696A (en) Sesamin/episesamin compositions
AP2002002674A0 (en) Clear Aqueous Anaesthetic composition.
MXPA04000839A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
GEP20084490B (en) Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof
EP1180369A4 (en) ANTI-FAS ANTIBODY MEDICAL COMPOSITIONS
NZ524742A (en) Bridged piperazine derivatives
BR0215904A (pt) Métodos e composições para prover glutamina